Regulation of cell homeostasis by fbx4
Regulation of cell homeostasis by fbx4
批准号:
8964361
负责人:
John Alan Diehl
金额:
$22.53万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-11-07 至 2016-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of my research centers on elucidation of the mechanisms whereby extra-cellular signals are sensed by the cell cycle machinery and regulate cell cycle progression in normal versus tumor cells. This information will provide the necessary framework to elucidate how growth regulatory pathways are subverted in neoplasia. Our current studies focus on how growth-signaling pathways regulate the mitogenically responsive D-type cyclins and more specifically, how these pathways regulate accumulation of an active, nuclear cyclin D1-dependent kinase in normal versus cancerous cells. The noted overexpression of cyclin D1 in multiple human cancers highlights the importance of elucidating the mechanisms that regulate cyclin D1 activity. While cyclin D1 overexpression is a consequence of gene amplification and chromosome translocation in a subset of cancers, decreased cyclin D1 protein degradation, which depends on its phosphorylation on Thr286, is thought to be the key factor in a majority of cancers. Our progress in the characterization of this mechanism of cyclin D1 overexpression in cancer has been hindered by lack of information regarding the nature of the E3 ubiquitin ligase that directs cyclin D1 proteolysis. We have recently identified the SCF(Fbx4-(B crystallin) that controls cyclin D1 ubiquitination and degradation. This discovery has provided essential information and tools to assess the mechanisms that contribute to regulation of cyclin D1 accumulation during normal tissue development and the potential deregulation of cyclin D1 during malignant transformation. The identification of this E3 ligase as well as our recent preliminary studies lead to the overarching hypothesis that the SCF(Fbx4 -(B crystallin) ligase, via coordinated recognition of phospho- cyclin D1 by Fbx4 and (B crystallin, plays a critical role in the maintenance of cell growth and tissue maintenance. Experiments proposed in this grant will determine the contribution of Fbx4 to tissue homeostasis in vivo (Aim 1). We will utilize fbx4-/- cells to conclusively define the role of Fbx4 in the regulation of cyclin D1 and cell proliferation (Aim 2). The identification of residues in Fbx4 necessary for substrate recognition will be identified through characterization of mutant Fbx4 alleles identified in melanoma.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Project 1- Micro-RNA-dependent signaling by the UPR
-
批准号:10247660
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:John Alan Diehl
-
依托单位:
Project 1- Micro-RNA-dependent signaling by the UPR
-
批准号:10017913
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:John Alan Diehl
-
依托单位:
Micro-RNA-dependent regulation of the UPR
-
批准号:8596329
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2013
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:8145722
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:7941448
-
项目类别:
-
资助金额:$16.6万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:8611904
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:8446158
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:8223243
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:7007686
-
项目类别:
-
资助金额:$29.95万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:6851131
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:7546563
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:7154794
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:7334751
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:8382057
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:8539279
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:9350164
-
项目类别:
-
资助金额:$25.86万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
ER STRESS AS EARLY SENSOR OF NUTRIENT DEPRIVATION
-
批准号:6990452
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:7713798
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:8327682
-
项目类别:
-
资助金额:$36.95万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:8742522
-
项目类别:
-
资助金额:$26.14万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位: